NEW YORK (GenomeWeb) – CareDx said today that its preliminary fourth quarter revenues rose 85 percent to 88 percent year over year, thanks to an increase of about 115 percent in testing revenues during the quarter.

For the three months ended Dec. 31, 2018, the company expects revenues of $23.2 million to $23.5 million, compared with $12.5 million in the fourth quarter of 2017. Analysts are expecting revenues of $21.8 million for the quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.